PMID- 24625040
OWN - NLM
STAT- MEDLINE
DCOM- 20141217
LR  - 20220409
IS  - 1744-8379 (Electronic)
IS  - 1473-7167 (Linking)
VI  - 14
IP  - 2
DP  - 2014 Apr
TI  - The minimum clinically important difference for EQ-5D index: a critical review.
PG  - 221-33
LID - 10.1586/14737167.2014.894462 [doi]
AB  - The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most 
      common instrument to value health outcomes under the patient's perspective. 
      Several studies have investigated whether observed changes are meaningful to 
      patients, using a variety of approaches to estimate the minimum clinically 
      important difference (MCID). This study provides an overview of the state of art 
      of the estimation of the MCID for the three-level EQ-5D index based on the UK 
      scoring algorithm, critically assessing the available evidence. The interest in 
      estimation of MCID for the EQ-5D has been increasing in recent years. However, 
      some additional standardization in the estimation procedures may be of value, in 
      order to enhance the ability to make comparisons across measures and disease 
      areas. Further methodological research might also contribute to reducing gaps 
      between theory and practice.
FAU - Coretti, Silvia
AU  - Coretti S
AD  - Dr. Catholic University of Sacred Hearth - Faculty of Economics, L.go F. Vito 1, 
      Rome 00168, Italy.
FAU - Ruggeri, Matteo
AU  - Ruggeri M
FAU - McNamee, Paul
AU  - McNamee P
LA  - eng
GR  - HERU1/CSO_/Chief Scientist Office/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PL  - England
TA  - Expert Rev Pharmacoecon Outcomes Res
JT  - Expert review of pharmacoeconomics & outcomes research
JID - 101132257
SB  - IM
MH  - Europe
MH  - Humans
MH  - *Quality of Life
MH  - *Surveys and Questionnaires
EDAT- 2014/03/15 06:00
MHDA- 2014/12/18 06:00
CRDT- 2014/03/15 06:00
PHST- 2014/03/15 06:00 [entrez]
PHST- 2014/03/15 06:00 [pubmed]
PHST- 2014/12/18 06:00 [medline]
AID - 10.1586/14737167.2014.894462 [doi]
PST - ppublish
SO  - Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33. doi: 
      10.1586/14737167.2014.894462.